title: Which antithyroid drug regimen in paediatric Graves' disease?
authors: Department of Paediatric Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
authors: Daniel
authors: D
authors: Schenk
authors: Malcolm
authors: M
authors: Donaldson
authors: Tim
authors: T
authors: Cheetham
mesh_terms: D000293:Adolescent; D013956:Antithyroid Agents / Q000627:therapeutic use*; D002231:Carbimazole / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D054796:Drug Dosage Calculations; D006111:Graves Disease / Q000188:drug therapy* / Q000453:epidemiology; D020249:Hormone Replacement Therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D017410:Practice Guidelines as Topic; D011441:Propylthiouracil / Q000009:adverse effects; D013963:Thyroid Hormones / Q000008:administration & dosage; D006113:United Kingdom / Q000453:epidemiology
chemical_list: D013956:Antithyroid Agents; D013963:Thyroid Hormones; D011441:Propylthiouracil; D002231:Carbimazole